Title
Telavancin Telavancin
Author
Faculty/Department
Faculty of Pharmaceutical, Biomedical and Veterinary Sciences. Pharmacy
Publication type
article
Publication
Subject
Pharmacology. Therapy
Source (journal)
Nature reviews drug discovery
Volume/pages
8(2009) :12 , p. 929-930
ISSN
1474-5313
Carrier
E
Target language
French (fre)
Full text (Publishers DOI)
Affiliation
University of Antwerp
Abstract
In September 2009, telavancin (Vibativ; Theravance/Astellas Pharma), a lipoglycopeptide antibiotic, was approved by the US FDA for the treatment of adult patients with complicated skin and skin structure infections.
Handle